Woodline Partners LP Allovir, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.68 - $2.39 $302,149 - $1.06 Million
444,338 Added 21.5%
2,511,004 $1.71 Million
Q3 2023

Nov 14, 2023
BUY
$2.15 - $3.64 $728,127 - $1.23 Million
338,664 Added 19.6%
2,066,666 $4.44 Million
Q2 2023

Aug 14, 2023
BUY
$3.17 - $5.82 $2.31 Million - $4.24 Million
728,002 Added 72.8%
1,728,002 $5.88 Million
Q1 2023

May 15, 2023
SELL
$3.94 - $7.05 $343,134 - $613,984
-87,090 Reduced 8.01%
1,000,000 $3.94 Million
Q4 2022

Feb 14, 2023
SELL
$4.7 - $9.98 $14 - $29
-3 Reduced -0.0%
1,087,090 $5.58 Million
Q4 2021

Feb 14, 2022
SELL
$12.94 - $25.99 $4.82 Million - $9.68 Million
-372,455 Reduced 25.52%
1,087,093 $14.1 Million
Q3 2021

Nov 15, 2021
BUY
$16.97 - $25.06 $571,261 - $843,594
33,663 Added 2.36%
1,459,548 $36.6 Million
Q2 2021

Aug 16, 2021
BUY
$19.44 - $25.06 $4.78 Million - $6.16 Million
245,951 Added 20.84%
1,425,885 $28.1 Million
Q1 2021

May 17, 2021
BUY
$20.81 - $45.5 $2.91 Million - $6.37 Million
140,054 Added 13.47%
1,179,934 $27.6 Million
Q4 2020

Feb 16, 2021
SELL
$23.94 - $46.81 $3.62 Million - $7.07 Million
-151,134 Reduced 12.69%
1,039,880 $40 Million
Q3 2020

Nov 16, 2020
BUY
$21.05 - $42.7 $25.1 Million - $50.9 Million
1,191,014 New
1,191,014 $32.8 Million

Others Institutions Holding ALVR

# of Institutions
63
Shares Held
44.6M
Call Options Held
14.9K
Put Options Held
200
View Full List

About Allovir, Inc.

ALVR Quotes by TradingView
  • Ticker ALVR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,063,400
  • Market Cap $50.3M
  • Description
  • Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...
More about ALVR
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email